Scott Kochenower
Foot & Ankle Surgery · Lawton, OKNPI 1174848790
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.0%), education and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 39.6% of the total. Reporting peaked in 2020 at $3,489 and has fallen 83.1% since, to $589 in 2025.
Across 93 payments — averaging $98.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$4K
- Arthrex$2K
- Pylant Medical$2K
- Trice Medical, Inc.$353
- Smith+Nephew$301
- Stryker$202
- plus $731 from 15 others
What the payments were for
- Travel & lodging$2,40426%
- Food & beverage$3,83142%
- Education$2,88232%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 25 | $3,608 |
| Arthrex | 10 | $2,249 |
| Pylant Medical | 11 | $1,674 |
| Trice Medical, Inc. | 3 | $353 |
| Smith+Nephew | 12 | $301 |
| Stryker | 3 | $202 |
| Organogenesis Inc. | 7 | $193 |
| Johnson & Johnson | 5 | $157 |
| Zimmer Biomet | 1 | $117 |
| AbbVie | 2 | $40 |
| Tactile Systems Technology Inc | 2 | $38 |
| Bioventus LLC | 2 | $35 |
| Zyla Life Sciences, Inc. | 2 | $22 |
| Restor3d, Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Averitas Pharma Inc. | 1 | $18 |
| Orthofix Medical, Inc. | 1 | $18 |
| Solventum Corporation | 1 | $14 |
| Merck | 1 | $13 |
| Osiris Therapeutics Inc. | 1 | $13 |
| Pacira Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,117 in reported general payments places this provider in the 70th percentile of 71 foot & ankle surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $217 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $171 |
| Methylprednisolone | 23 | $157 |
| Doxycycline Hyclate | 13 | $104 |
| Meloxicam | 14 | $22 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Lawton
- William SmithShawnee$277K
- Wesley StotlerTulsa$268K
- Andronica HandieTulsa$149K
- Henry SpingolaOklahoma City$48K
- Jessica FaughtOklahoma City$19K
- Brandon KitchensTulsa$19K
- Megan FilkinsEdmond$15K
- James DaviesTulsa$15K
- Shea CharbeneauEdmond$14K
- Matthew CarsonNorman$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.